
Currently, in early drug discovery, compounds that are formulated for zzso experiments are increasingly characterized as being zzso and poorly zzso Typical examples of intravenous zzso for these compounds include zzso solutions at zzso high or low zzso zzso solutions, solutions in zzso zzso zzso solutions, mixed zzso solutions, zzso fat zzso or zzso and zzso zzso designed to determine the intrinsic zzso behavior of a new drug entity zzso are complicated as, depending upon the zzso disposition in the zzso can be zzso This may be due to slow or incomplete dissolution of injected zzso zzso in the zzso delayed release from the dosing vehicle, competition between compound and zzso ingredients for transport and metabolism mechanisms, or altered binding to blood zzso The most important zzso for the successful development of a zzso dosing vehicle is the required zzso zzso the zzso technique used to determine drug concentration in the body is sensitive enough to allow compound administration at low doses, screening zzso at comparatively low zzso may be zzso In this way, zzso approaches that may potentially impact the zzso behavior of the compound of interest can be zzso 

